Kjell Öberg, Professor of Endocrine Oncology, Uppsala University, former chairman of the Dept. of Endocrine Oncology, University Hospital. One of the founders of ENETS and NANETS with 650 publications.

Pioneering treatment with somatostatin analogs and IFN, PET imaging, biomarkers: CgA, NETest.

Aldo Scarpa is Chair of the Department of Pathology at the University of Verona and Director of the ARC-Net Centre for Applied Research on Cancer. He received his MD from the University of Padua and his PhD in Molecular Pathology from the University of Verona. He trained in several international centres in Europe, USA and Japan. The research focus of Prof Scarpa is the translation into clinical practice of molecular subclassifications of cancers with prognostic-diagnostic-therapeutic relevance. He has published over 700 papers with an H index of 92. His interest in neuroendocrine neoplasms dates back to 1992 and ranges from histopathology and staging/grading to molecular characterisation as testified by his scientific production in the field.

Wolfgang Weber, MD is Professor and Chair of the Department of Nuclear Medicine at the Technical University of Munich in Germany (TUM). Dr. Weber’s research is focused on molecular imaging of cancer for planning and monitoring of therapeutic interventions. He is also interested in targeted radionuclide therapy of cancer and theranostics.

Dr. Heloisa Soares is a medical oncologist with a focus in neuroendocrine cancer. She is an associate professor at the Huntsman Cancer Institute (HCI) at University of Utah. She serves as the Medical Director for the Clinical Trials Office as well as the co-physician leader in the GI Clinical Trials Research Group at HCI. In 2019, she was elected as a member of the board of directors for The North American Neuroendocrine Tumor Society (NANETS). Additionally, she is a member of the NCI NET taskforce and part of the Neuroendocrine and Adrenal Tumors NCCN Clinical Practice Guidelines in Oncology. Currently, she is the National PI for the first adjuvant clinical trial in pancreas nets.